German Registry for Marginal Zone Lymphoma and Follicular Lymphoma

Recruiting

• Conditions: C83; C82; Non-follicular lymphoma; Follicular lymphoma

• Registration Number: DRKS00021517
• Lead Sponsor: niversitätsklinikum Ulm

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-05-05
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 1500

Inclusion Criteria

Confirmation of histological diagnosis of MZoL and FL by a reference pathologist.
Consent form signed by the patient.

Exclusion Criteria

Lack of consent.
Lack of legal capacity or insight.
Inclusion of active therapy of FL in a clinical trial.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Experience in the sense of gaining knowledge on the ground of daily practice is to be gathered based on an accompanying project of the reference pathologists, which in turn contributes to quality assurance. <br>The existing exchange of experience within the scope of the pilot phase of the registry is to be extended and expanded to the FL, and experiences from registry activities are to be passed on promptly, which ultimately also serves the purpose of care and quality assurance.

Secondary Outcome Measures

Name	Time	Method
The current register with the participating centres offers the chance to establish a national biobank for the relatively rare entity of the MZoL. The aim would be to establish the collection of biomaterials through the register.